Ontario Institute for Cancer Research
@oicr.on.ca
Bringing health and economic benefits to the people of Ontario through world-leading cancer research. Views expressed are those of OICR.
Read the latest news from OICR at: https://oicr.on.ca/news/
Read the latest news from OICR at: https://oicr.on.ca/news/
Reposted by Ontario Institute for Cancer Research
The Marathon Continues.
The Government of Canada has announced $80M for the next phase of the Marathon of Hope Cancer Centres Network, catalyzing up tp $160M with matching funds.
We’re getting closer to finishing what Terry started, but there’s more to do.
The next phase starts today.
The Government of Canada has announced $80M for the next phase of the Marathon of Hope Cancer Centres Network, catalyzing up tp $160M with matching funds.
We’re getting closer to finishing what Terry started, but there’s more to do.
The next phase starts today.
September 24, 2026 at 2:34 PM
The Marathon Continues.
The Government of Canada has announced $80M for the next phase of the Marathon of Hope Cancer Centres Network, catalyzing up tp $160M with matching funds.
We’re getting closer to finishing what Terry started, but there’s more to do.
The next phase starts today.
The Government of Canada has announced $80M for the next phase of the Marathon of Hope Cancer Centres Network, catalyzing up tp $160M with matching funds.
We’re getting closer to finishing what Terry started, but there’s more to do.
The next phase starts today.
Today marks the beginning of a new era at OICR and for cancer research in Ontario as Dr. Aaron Schimmer steps into his role as the Institute's President and Scientific Director. We welcome Dr. Schimmer as he joins us in our work to accelerate cancer research in Ontario.
https://bit.ly/4pT7Tb4
https://bit.ly/4pT7Tb4
August 4, 2026 at 4:00 PM
Today marks the beginning of a new era at OICR and for cancer research in Ontario as Dr. Aaron Schimmer steps into his role as the Institute's President and Scientific Director. We welcome Dr. Schimmer as he joins us in our work to accelerate cancer research in Ontario.
https://bit.ly/4pT7Tb4
https://bit.ly/4pT7Tb4
👩🏻💻 Read about how Mya Thompson is informing researcher training and data access procedures for the Ontario Hereditary Cancer Research Network as part of a unique summer internship https://bit.ly/4g4adZu
#datagovernance | #indigenoushealth | #cancerresearch | #OICR | #hereditarycancers
#datagovernance | #indigenoushealth | #cancerresearch | #OICR | #hereditarycancers
Mya Thompson is helping shape the future of Indigenous data governance in cancer research - Ontario Institute for Cancer Research
As part of a unique summer internship, Thompson is informing researcher training and data access procedures for the Ontario Hereditary Cancer Research Network (OHCRN). With a lifelong interest in health sciences and a passion for promoting equity for In...
bit.ly
July 30, 2026 at 7:40 PM
👩🏻💻 Read about how Mya Thompson is informing researcher training and data access procedures for the Ontario Hereditary Cancer Research Network as part of a unique summer internship https://bit.ly/4g4adZu
#datagovernance | #indigenoushealth | #cancerresearch | #OICR | #hereditarycancers
#datagovernance | #indigenoushealth | #cancerresearch | #OICR | #hereditarycancers
3D ultrasound pioneer transforming cancer imaging around the world: Over two decades as Co-Director of OICR’s Imaging Program, Dr. Aaron Fenster has developed 3D ultrasound systems that are improving cancer diagnosis and treatment. https://bit.ly/3QYzxq7
June 23, 2026 at 4:00 PM
3D ultrasound pioneer transforming cancer imaging around the world: Over two decades as Co-Director of OICR’s Imaging Program, Dr. Aaron Fenster has developed 3D ultrasound systems that are improving cancer diagnosis and treatment. https://bit.ly/3QYzxq7
Watch our latest "Ask a Cancer Researcher" video with Dr. Raymond Kim to find out how vaccines are being developed to prevent cancers in individuals living with Lynch syndrome, who are at a much greater risk of developing cancer.
#OICR #cancerresearch #immunotherapy #cancervaccines #Lynchsyndrome
#OICR #cancerresearch #immunotherapy #cancervaccines #Lynchsyndrome
June 9, 2026 at 7:46 PM
Watch our latest "Ask a Cancer Researcher" video with Dr. Raymond Kim to find out how vaccines are being developed to prevent cancers in individuals living with Lynch syndrome, who are at a much greater risk of developing cancer.
#OICR #cancerresearch #immunotherapy #cancervaccines #Lynchsyndrome
#OICR #cancerresearch #immunotherapy #cancervaccines #Lynchsyndrome
🔍 TMIST is one of the largest #breastcancer screening studies ever conducted and is working to find out if a newer 3D imaging technology outperforms standard #mammography.
Read more about TMIST, 3D mammography and how Canadian researchers are playing a key role. 👉 https://bit.ly/4x6ubt4
Read more about TMIST, 3D mammography and how Canadian researchers are playing a key role. 👉 https://bit.ly/4x6ubt4
Massive international clinical trial aims to answer a pivotal question in breast cancer screening - Ontario Institute for Cancer Research
TMIST, co-led by Canadian researchers, is working to determine whether a newer form of breast imaging can better detect aggressive breast cancers. The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) is one of the largest breast cancer screeni...
oicr.on.ca
June 8, 2026 at 5:37 PM
🔍 TMIST is one of the largest #breastcancer screening studies ever conducted and is working to find out if a newer 3D imaging technology outperforms standard #mammography.
Read more about TMIST, 3D mammography and how Canadian researchers are playing a key role. 👉 https://bit.ly/4x6ubt4
Read more about TMIST, 3D mammography and how Canadian researchers are playing a key role. 👉 https://bit.ly/4x6ubt4
Dr. Aaron Schimmer to join OICR as President and Scientific Director: the Institute will welcome the internationally recognized clinician-scientist and research leader in August 2026.
https://bit.ly/4wSFZin
https://bit.ly/4wSFZin
May 27, 2026 at 6:05 PM
Dr. Aaron Schimmer to join OICR as President and Scientific Director: the Institute will welcome the internationally recognized clinician-scientist and research leader in August 2026.
https://bit.ly/4wSFZin
https://bit.ly/4wSFZin
⚡ Exciting breakthrough from OICR’s Drug Discovery team.
In collaboration with @ucsanfrancisco.bsky.social, they have developed a new way to stop #HIV from replicating. This approach is unlike any existing therapy and could lead to a new class of antiviral medications.
🧪 https://bit.ly/4nHYYZ3
In collaboration with @ucsanfrancisco.bsky.social, they have developed a new way to stop #HIV from replicating. This approach is unlike any existing therapy and could lead to a new class of antiviral medications.
🧪 https://bit.ly/4nHYYZ3
Self-Dimerization Induced Proximity Targeting Chimeras (SDIPTAC) Lead to DCAF1 Loss of Function and Inhibition of HIV Replication
DCAF1 is a donut shaped WD40 repeat protein and a substrate receptor of two distinct E3 ligases. In HIV-1 infection, the viral protein Vpr binds to the top surface of DCAF1, changes its substrate specificity to degrade human proteins involved in antivir...
pubs.acs.org
May 21, 2026 at 2:41 PM
⚡ Exciting breakthrough from OICR’s Drug Discovery team.
In collaboration with @ucsanfrancisco.bsky.social, they have developed a new way to stop #HIV from replicating. This approach is unlike any existing therapy and could lead to a new class of antiviral medications.
🧪 https://bit.ly/4nHYYZ3
In collaboration with @ucsanfrancisco.bsky.social, they have developed a new way to stop #HIV from replicating. This approach is unlike any existing therapy and could lead to a new class of antiviral medications.
🧪 https://bit.ly/4nHYYZ3
❇️ Our new CATALYST funding stream is supporting four studies to unlock insights from existing patient samples and data, maximizing past research to drive future breakthroughs into the detection, diagnosis and treatment of cancer.
News release 👉 https://bit.ly/4flsNfJ
#CancerResearch #OICR
News release 👉 https://bit.ly/4flsNfJ
#CancerResearch #OICR
OICR supports four new studies seeking cancer insights from existing patient samples and data - Ontario Institute for Cancer Research
CATALYST will speed progress toward better detection, diagnosis and treatment for patients. May 13, 2026, ONTARIO — Four new research studies funded by the Ontario Institute for Cancer Research (OICR)...
bit.ly
May 14, 2026 at 1:57 PM
❇️ Our new CATALYST funding stream is supporting four studies to unlock insights from existing patient samples and data, maximizing past research to drive future breakthroughs into the detection, diagnosis and treatment of cancer.
News release 👉 https://bit.ly/4flsNfJ
#CancerResearch #OICR
News release 👉 https://bit.ly/4flsNfJ
#CancerResearch #OICR
Congratulations to NerView CEO and founder Mann Parikh and his team on winning FACIT’s Ernsting Entrepreneurship Award! Their promising technology can reduce the risk of nerve damage during surgery, helping patients better recover and maintain their quality of life. https://bit.ly/431H7mb
May 13, 2026 at 4:00 PM
Congratulations to NerView CEO and founder Mann Parikh and his team on winning FACIT’s Ernsting Entrepreneurship Award! Their promising technology can reduce the risk of nerve damage during surgery, helping patients better recover and maintain their quality of life. https://bit.ly/431H7mb
What's next in cancer research? We asked OICR's Dr. Michelle Brazas, and while the computational biologist is upbeat about the potential of AI, something else in cancer research has really grabbed her attention. Watch to find out more! 🎥❓👩🔬
#OICR #cancerresearch
#OICR #cancerresearch
May 12, 2026 at 5:01 PM
What's next in cancer research? We asked OICR's Dr. Michelle Brazas, and while the computational biologist is upbeat about the potential of AI, something else in cancer research has really grabbed her attention. Watch to find out more! 🎥❓👩🔬
#OICR #cancerresearch
#OICR #cancerresearch
🔔 Funding opportunity: OICR’s Clinical Translation program is inviting applications for Clinical Acceleration Team Awards to support multi‑centre clinical trials with molecular (minimal) residual disease as a component.
🗓️ Concept submissions due July 30, 2026
Learn more: oicr.on.ca/cata-rfa-2026/
🗓️ Concept submissions due July 30, 2026
Learn more: oicr.on.ca/cata-rfa-2026/
April 29, 2026 at 5:30 PM
🔔 Funding opportunity: OICR’s Clinical Translation program is inviting applications for Clinical Acceleration Team Awards to support multi‑centre clinical trials with molecular (minimal) residual disease as a component.
🗓️ Concept submissions due July 30, 2026
Learn more: oicr.on.ca/cata-rfa-2026/
🗓️ Concept submissions due July 30, 2026
Learn more: oicr.on.ca/cata-rfa-2026/
👨⚕️🎥 We are back with another Ask A Cancer Researcher video! Watch Dr. Rob Grant explain how our DNA can be used to help choose the best treatment for a particular cancer. 🔎🧬 https://bit.ly/48gj4D9
#cancerresearch #pancreaticcancer #OICR #precisionmedicine #personalizedmedicine #BRCA
#cancerresearch #pancreaticcancer #OICR #precisionmedicine #personalizedmedicine #BRCA
Can DNA testing help find the right cancer treatment?
YouTube video by Ontario Institute for Cancer Research - OICR
www.youtube.com
April 21, 2026 at 4:26 PM
👨⚕️🎥 We are back with another Ask A Cancer Researcher video! Watch Dr. Rob Grant explain how our DNA can be used to help choose the best treatment for a particular cancer. 🔎🧬 https://bit.ly/48gj4D9
#cancerresearch #pancreaticcancer #OICR #precisionmedicine #personalizedmedicine #BRCA
#cancerresearch #pancreaticcancer #OICR #precisionmedicine #personalizedmedicine #BRCA
OICR is leading a new Ontario‑wide collaboration focused on advancing molecular residual disease research, using cutting‑edge blood tests to detect tiny traces of cancer that can remain after treatment and lead to recurrence.
Read more 👉 https://bit.ly/4enOj2P
#OICR #cancerresearch
Read more 👉 https://bit.ly/4enOj2P
#OICR #cancerresearch
Ontario collaboration aims to predict and prevent cancer recurrence before it happens - Ontario Institute for Cancer Research
OICR is leading a province-wide initiative to advance molecular residual disease (MRD) research and bring tests to patients. “Did you get it all?” It's often the first question a patient asks after cancer treatment, and one of the toughest questions for...
bit.ly
April 16, 2026 at 2:00 PM
OICR is leading a new Ontario‑wide collaboration focused on advancing molecular residual disease research, using cutting‑edge blood tests to detect tiny traces of cancer that can remain after treatment and lead to recurrence.
Read more 👉 https://bit.ly/4enOj2P
#OICR #cancerresearch
Read more 👉 https://bit.ly/4enOj2P
#OICR #cancerresearch
Reposted by Ontario Institute for Cancer Research
In a recent interview with the @oicr.on.ca, Dr. Richard Kim discussed his research studying how rare genetic differences can impact the way patients with colorectal cancer respond to chemotherapy.
To read the full interview, visit OICR’s website: oicr.on.ca/oicr-funded-...
To read the full interview, visit OICR’s website: oicr.on.ca/oicr-funded-...
April 10, 2026 at 2:38 PM
In a recent interview with the @oicr.on.ca, Dr. Richard Kim discussed his research studying how rare genetic differences can impact the way patients with colorectal cancer respond to chemotherapy.
To read the full interview, visit OICR’s website: oicr.on.ca/oicr-funded-...
To read the full interview, visit OICR’s website: oicr.on.ca/oicr-funded-...
OICR Drug Discovery is teaming up with Dr. Sheila Singh at McMaster University to develop a potentially game-changing treatment option for the most aggressive form of #medulloblastoma. This research could offer less toxic treatment to stop deadly childhood #braincancer https://bit.ly/4tGQL90
April 13, 2026 at 2:12 PM
OICR Drug Discovery is teaming up with Dr. Sheila Singh at McMaster University to develop a potentially game-changing treatment option for the most aggressive form of #medulloblastoma. This research could offer less toxic treatment to stop deadly childhood #braincancer https://bit.ly/4tGQL90
📣 News release: OICR's Cancer Therapeutics Innovation Pipeline is supporting four Ontario-based teams to develop the next generation of cancer therapies, designed to be more effective at destroying tumours, have reduced side effects and make cancer less likely to return. https://bit.ly/41vaywi
Newly funded projects to develop more effective drugs with fewer side effects for hard-to-treat cancers - Ontario Institute for Cancer Research
OICR funding is leveraging Ontario’s drug discovery expertise to answer the call for improved treatment options April 9, 2026 (Toronto) – Better cancer care depends on better treatment options. That’s...
bit.ly
April 10, 2026 at 8:17 PM
📣 News release: OICR's Cancer Therapeutics Innovation Pipeline is supporting four Ontario-based teams to develop the next generation of cancer therapies, designed to be more effective at destroying tumours, have reduced side effects and make cancer less likely to return. https://bit.ly/41vaywi
Dr. Glenn Bauman recently completed his time with OICR’s Clinical Translation program. In this Q&A he chats about his longtime involvement with OICR, its critical support of his practice-changing prostate cancer research and what’s new in cancer research in #LdnOnt.
https://bit.ly/4kq2QvY
https://bit.ly/4kq2QvY
Q&A: Glenn Bauman on precision imaging, clinical translation, and cancer research in Ontario - Ontario Institute for Cancer Research
Dr. Glenn Bauman recently completed his time acting as an advisor within OICR’s Clinical Translation program. In this Q and A he chats about his longtime involvement with OICR, the Institute’s critica...
oicr.on.ca
February 12, 2026 at 3:00 PM
Dr. Glenn Bauman recently completed his time with OICR’s Clinical Translation program. In this Q&A he chats about his longtime involvement with OICR, its critical support of his practice-changing prostate cancer research and what’s new in cancer research in #LdnOnt.
https://bit.ly/4kq2QvY
https://bit.ly/4kq2QvY
OICR Investigator Dr. Brian Nieman is exploring how chemotherapy for the treatment of leukemia in children impacts brain development, which can put them at risk of long-term cognitive or behavioural problems.
https://bit.ly/45IPZ27
https://bit.ly/45IPZ27
January 21, 2026 at 7:43 PM
OICR Investigator Dr. Brian Nieman is exploring how chemotherapy for the treatment of leukemia in children impacts brain development, which can put them at risk of long-term cognitive or behavioural problems.
https://bit.ly/45IPZ27
https://bit.ly/45IPZ27
Reposted by Ontario Institute for Cancer Research
📣 Tomorrow! 📣
Don’t miss this virtual event exploring how Network-funded health technology assessment projects are informing advances in precision oncology!
📆: Thursday, January 15, 2026
⌚: 9am PT / 10am MT / 11am CT / 12pm ET / 1pm AT / 1:30pm NT
🔗 Register now: tinyurl.com/5dbdzsfb
Don’t miss this virtual event exploring how Network-funded health technology assessment projects are informing advances in precision oncology!
📆: Thursday, January 15, 2026
⌚: 9am PT / 10am MT / 11am CT / 12pm ET / 1pm AT / 1:30pm NT
🔗 Register now: tinyurl.com/5dbdzsfb
January 14, 2026 at 3:08 PM
📣 Tomorrow! 📣
Don’t miss this virtual event exploring how Network-funded health technology assessment projects are informing advances in precision oncology!
📆: Thursday, January 15, 2026
⌚: 9am PT / 10am MT / 11am CT / 12pm ET / 1pm AT / 1:30pm NT
🔗 Register now: tinyurl.com/5dbdzsfb
Don’t miss this virtual event exploring how Network-funded health technology assessment projects are informing advances in precision oncology!
📆: Thursday, January 15, 2026
⌚: 9am PT / 10am MT / 11am CT / 12pm ET / 1pm AT / 1:30pm NT
🔗 Register now: tinyurl.com/5dbdzsfb
New ICGC ARGO data dictionary, developed by OICR, to harmonize genomic and clinical data collected from around the world https://bit.ly/3NfvTGd
#genomics #cancerresearch
#genomics #cancerresearch
January 12, 2026 at 8:50 PM
New ICGC ARGO data dictionary, developed by OICR, to harmonize genomic and clinical data collected from around the world https://bit.ly/3NfvTGd
#genomics #cancerresearch
#genomics #cancerresearch
Season’s greetings to everyone in the Ontario cancer research community and beyond. Thank you to all of those who worked with us and supported the Institute during our milestone 20th year and all those who have been a part of our success. Happy holidays and best wishes for a great year ahead!
December 18, 2025 at 5:00 PM
Season’s greetings to everyone in the Ontario cancer research community and beyond. Thank you to all of those who worked with us and supported the Institute during our milestone 20th year and all those who have been a part of our success. Happy holidays and best wishes for a great year ahead!
Two decades ago, Ontario set out to create a world-class cancer research institute. Today, OICR is a cornerstone of Ontario’s life sciences ecosystem. Watch the video to see how far we’ve come, and where we’re headed next.
https://oicr.on.ca/
#OICR20Years #cancerresearch
https://oicr.on.ca/
#OICR20Years #cancerresearch
December 17, 2025 at 6:22 PM
Two decades ago, Ontario set out to create a world-class cancer research institute. Today, OICR is a cornerstone of Ontario’s life sciences ecosystem. Watch the video to see how far we’ve come, and where we’re headed next.
https://oicr.on.ca/
#OICR20Years #cancerresearch
https://oicr.on.ca/
#OICR20Years #cancerresearch
Aqsa, who lost her father and sister to cancer, works in clinical genome interpretation at OICR, preparing reports for patients. She enjoys this work, not just because she is helping patients but also that she able to "not let them be alone in their fears". https://bit.ly/4j0shUl #changedmylife
December 16, 2025 at 8:35 PM
Aqsa, who lost her father and sister to cancer, works in clinical genome interpretation at OICR, preparing reports for patients. She enjoys this work, not just because she is helping patients but also that she able to "not let them be alone in their fears". https://bit.ly/4j0shUl #changedmylife
🧬 Protein that unties tangled DNA linked to hotspots of cancer mutations: Research from @reimand.bsky.social and his collaborators associated a chemotherapy-related cellular process with genetic mutations and used it to identify novel cancer driver alterations. https://bit.ly/4iMcV5B
Protein that unties tangled DNA linked to hotspots of cancer mutations - Ontario Institute for Cancer Research
Research from the Ontario Institute for Cancer Research associated a chemotherapy-related cellular process with genetic mutations and used it to identify novel cancer driver alterations. New research ...
oicr.on.ca
December 8, 2025 at 6:00 PM
🧬 Protein that unties tangled DNA linked to hotspots of cancer mutations: Research from @reimand.bsky.social and his collaborators associated a chemotherapy-related cellular process with genetic mutations and used it to identify novel cancer driver alterations. https://bit.ly/4iMcV5B